Insider · CIK 0001307632

Hawkins Richard J

Reports to the SEC for 4 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001307632

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−921 sh	—	—	1,843
2026-10-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+921 sh	—	—	2,450
2026-07-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+922 sh	—	—	1,529
2026-07-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−922 sh	—	—	2,764
2026-05-14	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,686 sh	—	—	3,686
2026-05-14	CNSYCERENOME, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,686 sh	—	—	3,686
2025-12-09	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	161,326
2025-11-14	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+5,860 sh	$1.46	+$8,555.6	121,326
2025-11-14	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,860 sh	—	—	0
2025-08-13	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+398K sh	—	—	397,794
2025-06-20	SVRASavara IncP Purchase	Director	PPurchase	+48.2K sh	$2.04	+$98.6K	115,466
2025-02-18	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.1K sh	—	—	40,122
2024-12-16	SVRASavara IncS Sale	Director	SSale	−8,000 sh	$3.32	−$26.6K	67,241
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−28.5K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−35.4K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−35.4K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−135K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−4,469 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−753K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−19.6K sh	—	—	0
2024-12-12	SVRASavara IncA Award	Director	AAward	+40K sh	—	—	75,241
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−35.4K sh	—	—	0
2024-09-13	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+4,000 sh	$1.50	+$5,996	15,188
2024-09-12	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+6,285 sh	$1.35	+$8,511.776	11,188
2024-09-11	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,650 sh	—	—	3,650
2024-05-08	CNSYCERENOME, INC. · Warrants (Right to buy)A Award	Director	AAward	+9,804 sh	—	—	9,804
2024-05-08	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+4,902 sh	$2.04	+$10K	4,903
2024-04-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,522 sh	$2.84	−$4,322.48	753,093
2024-04-01	LUMOS PHARMA, INC.A Award	Director, Chief Executive Officer	AAward	+4,500 sh	$2.84	+$12.8K	754,615
2024-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+35.4K sh	—	—	35,400
2024-02-22	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,250 sh	—	—	2,250
2024-02-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−690 sh	$3.01	−$2,076.9	750,115
2023-12-14	SVRASavara IncA Award	Director	AAward	+22.5K sh	—	—	35,241
2023-12-11	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+10.8K sh	$0.82	+$8,889.62	12,741
2023-12-11	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.8K sh	—	—	0
2023-04-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,522 sh	$3.31	−$5,037.82	750,805
2023-03-03	CNSYCERENOME, INC.P Purchase	Director	PPurchase	+1 sh	$1000.00	+$1,000	1
2023-02-15	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,182
2023-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+35.4K sh	—	—	35,400
2023-02-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−416 sh	$3.52	−$1,464.32	752,327
2023-02-01	LUMOS PHARMA, INC.A Award	Director, Chief Executive Officer	AAward	+4,500 sh	$3.52	+$15.8K	752,743
2022-12-13	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-12-07	SVRASavara Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,172 sh	—	—	0
2022-12-07	SVRASavara IncM Exercise/Conversion	Director	MExercise/Conversion	+1,172 sh	$0.65	+$761.8	1,900
2022-09-23	LUMOS PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+208 sh	$8.80	+$1,830.4	4,469
2022-09-21	LUMOS PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+2,214 sh	$8.84	+$19.6K	4,261
2022-09-20	LUMOS PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+1,506 sh	$8.75	+$13.2K	2,047
2022-09-19	LUMOS PHARMA, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+541 sh	$8.65	+$4,679.65	541
2022-04-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,466 sh	$9.23	−$13.5K	748,243
2022-02-01	LUMOS PHARMA, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−173 sh	$10.02	−$1,733.46	749,709

Recent filings

Accepted (ET)
Oct 14
Hawkins Richard J0001193125-26-409858
SEC(opens sec.gov)
Jul 14
Hawkins Richard J0001193125-26-292648
SEC(opens sec.gov)
May 184
Hawkins Richard J0001193125-26-228930
SEC(opens sec.gov)
Dec 114
Hawkins Richard J0001193125-25-316315
SEC(opens sec.gov)
Nov 174
Hawkins Richard J0001193125-25-284702
SEC(opens sec.gov)
Aug 154
Hawkins Richard J0000950170-25-109412
SEC(opens sec.gov)
Jun 234
Hawkins Richard J0000950170-25-088895
SEC(opens sec.gov)
Feb 204
Hawkins Richard J0000950170-25-024344
SEC(opens sec.gov)
Dec 164
Hawkins Richard J0000950170-24-136780
SEC(opens sec.gov)
Dec 134
Hawkins Richard J0001126234-24-000122
SEC(opens sec.gov)

Companies

Address

C/O PLUS THERAPEUTICS INC. 6420 LEVIT GREEN BOULEVARD, SUITE 310

HOUSTON, TX, 77021